KKR Real Estate Finance Trust Inc. (KREF) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | (m) | |
| Stock-based compensation | 7.37M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | (m) | |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $7.37M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | (m) | $7.61M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | $7.93M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | (m) | $8.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | $8.01M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | $8.09M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $8.26M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | (m) | $8.27M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | $8.27M | (m) | $458.44M | (m) | (m) | (m) | Reported |
| 2024-03-31 | (m) | (m) | $8.22M | (m) | $465.30M | (m) | (m) | (m) | Reported |
| 2023-12-31 | (m) | (m) | $8.07M | (m) | $458.80M | (m) | (m) | (m) | Reported |
| 2023-09-30 | (m) | (m) | $8.00M | (m) | $431.86M | (m) | (m) | (m) | Reported |
| 2023-06-30 | (m) | (m) | $8.00M | (m) | $380.56M | (m) | (m) | (m) | Reported |
| 2023-03-31 | (m) | (m) | $7.86M | (m) | $309.61M | (m) | (m) | (m) | Reported |
| 2022-12-31 | (m) | (m) | $7.83M | (m) | $236.09M | (m) | (m) | (m) | Reported |
| 2022-09-30 | (m) | (m) | $7.75M | (m) | $174.77M | (m) | (m) | (m) | Reported |
| 2022-06-30 | (m) | (m) | $7.61M | (m) | $137.29M | (m) | (m) | (m) | Reported |
| 2022-03-31 | (m) | (m) | $7.56M | (m) | $119.52M | (m) | (m) | (m) | Reported |
| 2021-12-31 | (m) | (m) | $7.43M | (m) | $114.44M | (m) | (m) | (m) | Reported |
| 2021-09-30 | (m) | (m) | $7.32M | (m) | $113.01M | (m) | (m) | (m) | Reported |
| 2021-06-30 | (m) | (m) | $6.68M | (m) | $112.01M | (m) | (m) | (m) | Reported |
| 2021-03-31 | (m) | (m) | $6.06M | (m) | $115.61M | (m) | (m) | (m) | Reported |
| 2020-12-31 | (m) | (m) | $5.68M | (m) | $127.31M | (m) | (m) | (m) | Reported |
| 2020-09-30 | (m) | (m) | $5.39M | (m) | $139.81M | (m) | (m) | (m) | Reported |
| 2020-06-30 | (m) | (m) | $5.04M | (m) | $156.57M | (m) | (m) | (m) | Reported |
| 2020-03-31 | (m) | (m) | $4.71M | (m) | $163.10M | (m) | (m) | (m) | Reported |
| 2019-12-31 | (m) | (m) | $4.09M | (m) | $158.86M | (m) | (m) | (m) | Reported |
| 2019-09-30 | (m) | (m) | $3.86M | (m) | $149.72M | (m) | (m) | (m) | Reported |
| 2019-06-30 | (m) | (m) | $3.11M | (m) | $127.46M | (m) | (m) | (m) | Reported |
| 2019-03-31 | (m) | (m) | $1.95M | (m) | $109.17M | (m) | (m) | (m) | Reported |
| 2018-12-31 | (m) | (m) | $1.97M | (m) | $85.02M | (m) | (m) | (m) | Reported |
| 2018-09-30 | (m) | (m) | $1.22M | (m) | $61.46M | (m) | (m) | (m) | Reported |
| 2018-06-30 | (m) | (m) | $945.00K | (m) | $43.53M | (m) | (m) | (m) | Reported |
| 2018-03-31 | (m) | (m) | $1.08M | (m) | $27.96M | (m) | (m) | (m) | Reported |
| 2017-12-31 | (m) | (m) | $65.00K | (m) | $21.22M | (m) | (m) | (m) | Reported |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | $0.00 | (m) | $7.43M | (m) | (m) | (m) | Reported |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $0.00 | (m) | $554.00K | (m) | (m) | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TRANSCONTINENTAL REALTY INVESTORS INC (TCI) | United States | $0.373B | 46.94 |
| GLADSTONE LAND Corp (LAND) | United States | $0.409B | -56.91 |
| Community Healthcare Trust Inc (CHCT) | United States | $0.410B | 24.97 |
| APARTMENT INVESTMENT & MANAGEMENT CO (AIV) | United States | $0.312B | 1.41 |
| Alpine Income Property Trust, Inc. (PINE) | United States | $0.299B | 55.73 |
| NexPoint Real Estate Finance, Inc. (NREF) | United States | $0.297B | 2.55 |
| FrontView REIT, Inc. (FVR) | United States | $0.445B | 328.46 |
| NEXPOINT DIVERSIFIED REAL ESTATE TRUST (NXDT) | United States | $0.277B | -3.74 |
| Lument Finance Trust, Inc. (LFT) | United States | $0.273B | -3.55 |
| Chicago Atlantic Real Estate Finance, Inc. (REFI) | United States | $0.272B | 7.76 |